Manage Your Liver
Q:

Fibrosis is the key to NASH progression, not the fat

Fibrosis is the key to NASH progression, not the fat
A:

“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”

 

NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is called NASH.

 

Currently, there is no cure for NASH. The standard treatment recommendation for NASH patients targets at reducing fat. Patients are recommended to lose weight by leading a healthy lifestyle with balanced diet and adequate exercise.

 

Fat is not actually the problem

 

It’s natural to think eliminating the cause of disease (which is fat for NASH) would lead to recovery, but recently, a study found that the accumulated fat in the liver isn’t the issue to disease progression. Instead, measures of the degree of fibrosis – the Ishak score, enhanced liver fibrosis (ELF) score were associated with progression to cirrhosis for patients. 

 

The study was presented at the International Liver Congress, the annual meeting of the European Association for the Study of the Liver (EASL). Howard Thomas, the honorary president of the meeting stated that the study sheds new light on how advanced NASH changes over time and what drives those changes. 

 

“The bottom line was that it wasn't so much an issue of the fat itself, but of the stiffness of the liver”, Thomas said.

 

The study was conducted over a period of 96 weeks, with 477 NASH patients enrolled. In the study, histology was determined by liver biopsies taken at baseline (start of the study), week 48 (middle of the study), and week 96 (end of the study); quantifying fibrosis with an Ishak score and ELF score. Analysis showed that a higher ELF score at baseline and worsening over time predicted progression to cirrhosis. More importantly, it was found that no patients progressed if they had an improved Ishak score throughout the study.

 

Prevent and stop fibrosis

 

The liver is a unique organ that has the ability to recover itself. However when constant damage is done, e.g. chronic inflammation; fibrosis or scarring of the liver occurs as an attempt to limit tissue damage in response to chronic liver injury. Therefore, the key to preventing fibrosis is to stop inflammation, as inflammation is the major cause of liver damage. By stopping inflammation, fibrosis and progression of NASH can be halted or even reversed. This ensures that the risk of severe liver diseases is reduced in the long term.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Being one of the serious stages of liver disease, cirrhosis has long been known as a difficult liver condition to deal with. Not only does the liver gradually cease to function because of the scar tissue, but the medical conditions developed from cirrhosis such as portal hypertension pose extra threats to patients’ prognosis.    A promising approach to treat liver cirrhosis? Portal hypertension has always been regarded as a condit
A:
Being the leading cause of chronic liver diseases in the USA and Europe, Non-alcoholic Fatty Liver Disease (NAFLD) is gradually becoming a common health issue worldwide. According to a recent research, the global prevalence of NAFLD is estimated to be 24%, with South America and the Middle East having the highest rates of NAFLD patients.  NAFLD refers to the accumulation of excess fat in the liver of people who only drink little or no alcohol, and there’s a huge correlati
Hit Questions
A:
The liver carries out essential functions, including detoxifying harmful substances in your body, cleaning your blood and making new blood and other vital nutrients. Cirrhosis is scarring of the liver caused by long-term liver damage. The loss of liver cells turns into scar tissue which prevents the liver working normally, reducing or in some cases, completely losing liver function. Cirrhosis is a long-term chronic liver damage; it is often caused by chronic live
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
A:
ALT (Alanine Aminotransferase / SGPT) is a type of enzyme found in liver cells. When the liver cells are functioning normally, the ALT enzymes should be contained within the liver cells.    You can imagine each liver cells as a balloon, and the ALT enzymes are the air inside the balloon. When the balloon is damaged, the air will be released. And when the liver cells is damaged, ALT enzymes are released into the bloodstream, therefore we are able to find out the l
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us
Subscribe To Our Mailing List And
Never Miss Another Great Promotion!
Join our mailing list to receive latest new about our company, plus health articles. You will also be able to receive early bird discount from us!
Maybe Later, Thank you.
Subscribe success! You will receive latest new soon.